Analyze Diet
Pathogens (Basel, Switzerland)2024; 13(10); 865; doi: 10.3390/pathogens13100865

Equine Herpesvirus Type 1 ORF76 Encoding US9 as a Neurovirulence Factor in the Mouse Infection Model.

Abstract: Equine herpesvirus type 1 (EHV-1) causes rhinopneumonitis, abortion, and neurological outbreaks (equine herpesvirus myeloencephalopathy, EHM) in horses. EHV-1 also causes lethal encephalitis in small laboratory animals such as mice and hamsters experimentally. EHV-1 ORF76 is a homolog of HSV-1 US9, which is a herpesvirus kinase. Starting with an EHV-1 bacterial artificial chromosome clone of neuropathogenic strain Ab4p (pAb4p BAC), we constructed an ORF76 deletion mutant (Ab4p∆ORF76) by replacing ORF76 with the rpsLneo gene. Deletion of ORF76 had no influence on replication, cell-to-cell spread in cultured cells, or replication in primary neuronal cells. In Western blots of EHV-1-infected cell lysates, an EHV-1 US9-specific polyclonal antibody detected multiple bands ranging from 35 to 42 kDa. In a CBA/N1 mouse infection model following intranasal inoculation, the parent and Ab4p∆ORF76 revertant caused the same histopathology in the brain and olfactory bulbs. The parent, Ab4p∆ORF76, and revertant mutant replicated similarly in the olfactory mucosa, although Ab4p∆ORF76 was not transported to the olfactory bulbs and was unable to infect the CNS. These results indicated that ORF76 (US9) plays an essential role in the anterograde spread of EHV-1.
Publication Date: 2024-10-02 PubMed ID: 39452736PubMed Central: PMC11510313DOI: 10.3390/pathogens13100865Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This research investigates the role of the Equine Herpesvirus Type 1 (EHV-1) gene ORF76, which encodes the US9 protein, in viral neurovirulence using a mouse infection model.
  • The study demonstrates that ORF76 is crucial for the virus’s ability to spread to the central nervous system (CNS), impacting its neurovirulence.

Introduction and Background

  • Equine Herpesvirus Type 1 (EHV-1): A virus causing respiratory illness (rhinopneumonitis), abortions, and neurological disease (equine herpesvirus myeloencephalopathy – EHM) in horses.
  • Neurovirulence: The virus’s ability to infect and cause damage to the nervous system, leading to conditions such as encephalitis (brain inflammation).
  • Animal Models: Mice and hamsters are used experimentally to study EHV-1 infection and its mechanisms due to their susceptibility to lethal encephalitis caused by the virus.
  • US9 Homolog: EHV-1 ORF76 gene encodes a protein homologous to US9 in Herpes Simplex Virus 1 (HSV-1), which is associated with viral transport and kinase activity.

Objectives

  • To determine the function of the ORF76 gene in EHV-1 replication, spread, and neurovirulence.
  • To investigate how the deletion of ORF76 affects viral propagation in cultured cells, neuronal cells, and in vivo within mice.
  • To examine the role of ORF76 in viral transport from the olfactory mucosa to the brain and central nervous system (CNS).

Methods

  • Genetic Engineering: Created an ORF76 deletion mutant virus (Ab4p∆ORF76) from a neuropathogenic strain clone (pAb4p BAC) by replacing ORF76 with the rpsLneo gene for selection.
  • In Vitro Experiments: Measured viral replication and cell-to-cell spread in cultured cells and primary neuronal cells to assess the effect of ORF76 deletion.
  • Protein Detection: Used Western blotting with an EHV-1 US9-specific polyclonal antibody to detect the presence and characterize the size of the US9 protein bands in infected cells.
  • In Vivo Mouse Model: Inoculated CBA/N1 mice intranasally with either the parent virus, the ORF76 deletion mutant, or a revertant virus to analyze viral replication, brain pathology, and viral transport to the CNS.

Key Findings

  • Replication and Cell Spread: Deletion of ORF76 did not affect virus replication or spread in cultured and primary neuronal cells, indicating ORF76 is not essential for these processes.
  • Protein Expression: The US9 protein was detected as multiple bands of 35 to 42 kDa in infected cell lysates, confirming its expression during infection.
  • Neuroinvasion: The parent and revertant viruses caused similar brain and olfactory bulb pathology, whereas the ORF76 deletion mutant was unable to infect the CNS despite similar replication in the olfactory mucosa.
  • Viral Transport: ORF76 deletion mutant was deficient in anterograde transport from the olfactory mucosa to the olfactory bulbs and CNS, highlighting ORF76’s critical role in viral spread within the nervous system.

Conclusions

  • ORF76 (US9) protein is not necessary for viral replication or cell-to-cell spread in vitro but is essential for anterograde neuronal transport in vivo.
  • The inability of the ORF76 deletion mutant to reach the olfactory bulbs and CNS demonstrates the gene’s crucial role in EHV-1 neurovirulence.
  • This finding advances understanding of how EHV-1 spreads within the host nervous system and may inform strategies to mitigate or prevent neurological disease caused by EHV-1 in animals.

Implications for Future Research

  • Further studies could explore the molecular mechanisms by which ORF76 facilitates viral transport in neurons.
  • Investigating the potential of targeting ORF76 or its pathway for therapeutic intervention to block neurological infection by EHV-1.
  • Expanding research to other animal models and EHV-1 strains for broader understanding of neurovirulence factors.

Cite This Article

APA
Nayel M, Kasem S, Fukushi N, El-Habashi N, Elsify A, Salama A, Hassan H, Yanai T, Ohya K, Fukushi H. (2024). Equine Herpesvirus Type 1 ORF76 Encoding US9 as a Neurovirulence Factor in the Mouse Infection Model. Pathogens, 13(10), 865. https://doi.org/10.3390/pathogens13100865

Publication

ISSN: 2076-0817
NlmUniqueID: 101596317
Country: Switzerland
Language: English
Volume: 13
Issue: 10
PII: 865

Researcher Affiliations

Nayel, Mohamed
  • Department of Applied Veterinary Sciences, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
  • Department of Animal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt.
Kasem, Samy
  • Department of Applied Veterinary Sciences, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
  • Department of Virology, Faculty of Veterinary Medicine, Kafr Elsheikh University, Kafr Elsheikh 33516, Egypt.
Fukushi, Noriko
  • Department of Applied Veterinary Sciences, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
El-Habashi, Nagwan
  • Department of Pathology, Faculty of Veterinary Medicine, Kafr Elsheikh University, Kafr Elsheikh 33516, Egypt.
  • Department of Veterinary Pathology, Faculty of Applied Biological Science, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
Elsify, Ahmed
  • Department of Animal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt.
Salama, Akram
  • Department of Animal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt.
Hassan, Hany
  • Department of Animal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt.
Yanai, Tokuma
  • Department of Veterinary Pathology, Faculty of Applied Biological Science, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
Ohya, Kenji
  • Department of Applied Veterinary Sciences, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
Fukushi, Hideto
  • Department of Applied Veterinary Sciences, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
  • Department of Veterinary Pathology, Faculty of Applied Biological Science, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.

MeSH Terms

  • Animals
  • Herpesvirus 1, Equid / pathogenicity
  • Herpesvirus 1, Equid / genetics
  • Mice
  • Disease Models, Animal
  • Viral Proteins / genetics
  • Viral Proteins / metabolism
  • Herpesviridae Infections / virology
  • Herpesviridae Infections / veterinary
  • Virulence Factors / genetics
  • Virulence Factors / metabolism
  • Virus Replication
  • Brain / virology
  • Brain / pathology
  • Brain / metabolism
  • Mice, Inbred CBA
  • Gene Deletion
  • Neurons / virology
  • Neurons / pathology
  • Neurons / metabolism
  • Horses
  • Olfactory Bulb / virology
  • Olfactory Bulb / metabolism
  • Olfactory Bulb / pathology

Grant Funding

  • 17380181, 21380179 and 18H02343 / Japan Society for the Promotion of Science

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 55 references
  1. Patel J, Heldens J. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)—Epidemiology, disease and immunoprophylaxis: A brief review.. Vet. J. 2005;170:14–23.
    doi: 10.1016/j.tvjl.2004.04.018pubmed: 15993786google scholar: lookup
  2. Saxegaard F. Isolation and identification of equine rhinopneumonitis virus (equine abortion virus) from cases of abortion and paralysis.. Nordic Vet. Med. 1966;18:504–512.
  3. Allen G.P. Development of a Real-Time Polymerase Chain Reaction Assay for Rapid Diagnosis of Neuropathogenic Strains of Equine Herpesvirus-1.. J. Vet. Diagn. Investig. 2007;19:69–72.
    doi: 10.1177/104063870701900110pubmed: 17459834google scholar: lookup
  4. Goehring L.S., van Maanen C, van Sloet Oldruitenborgh-Oosterbaan M.M. Neurological syndromes among horses in The Netherlands. A 5 year retrospective survey (1999–2004). Vet. Q. 2005;27:11–20.
    doi: 10.1080/01652176.2005.9695182pubmed: 15835280google scholar: lookup
  5. Henninger R.W., Reed S.M., Saville W.J., Allen G.P., Hass G.F., Kohn C.W., Sofaly C. Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center.. J. Vet. Int. Med. 2007;21:157–165.
    pubmed: 17338164
  6. Lunn D, Davis-Poynter N, Flaminio M, Horohov D, Osterrieder K, Pusterla N, Townsend H. Equine herpesvirus-1 consensus statement.. J. Vet. Int. Med. 2009;23:450–461.
  7. Kohn C.W., Reed S.M., Sofaly C.D., Henninger R.W., Saville W.J., Allen G.P., Premanadan C. Transmission of EHV-1 by horses with EHV-1 myeloencephalopathy: Implications for biosecurity and review.. Clin. Tech. Equine Pract. 2006;5:60–66.
  8. Jackson T.A., Osburn B, Cordy D, Kendrick J. Equine herpesvirus 1 infection of horses: Studies on the experimentally induced neurologic disease.. Am. J. Vet. Res. 1977;38:709–719.
    pubmed: 195494
  9. Nugent J, Birch-Machin I, Smith K, Mumford J, Swann Z, Newton J, Bowden R, Allen G, Davis-Poynter N. Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks.. J. Virol. 2006;80:4047–4060.
  10. Leutenegger C, Madigan J, Mapes S, Thao M, Estrada M, Pusterla N. Detection of EHV-1 neuropathogenic strains using real-time PCR in the neural tissue of horses with myeloencephalopathy.. Vet. Rec. 2008;162:688.
    doi: 10.1136/vr.162.21.688pubmed: 18503069google scholar: lookup
  11. Smith K.L., Allen G.P., Branscum A.J., Cook R.F., Vickers M.L., Timoney P.J., Balasuriya U.B. The increased prevalence of neuropathogenic strains of EHV-1 in equine abortions.. Vet. Microbiol. 2010;141:5–11.
    doi: 10.1016/j.vetmic.2009.07.030pubmed: 19733451google scholar: lookup
  12. Vissani M, Becerra M, Perglione C.O., Tordoya M, Miño S, Barrandeguy M. Neuropathogenic and non-neuropathogenic genotypes of Equid Herpesvirus type 1 in Argentina.. Vet. Microbiol. 2009;139:361–364.
    doi: 10.1016/j.vetmic.2009.06.025pubmed: 19589651google scholar: lookup
  13. Yamada S, Matsumura T, Tsujimura K, Yamaguchi T, Ohya K, Fukushi H. Comparison of the growth kinetics of neuropathogenic and nonneuropathogenic equid herpesvirus type 1 (EHV-1) strains in cultured murine neuronal cells and the relevance of the D/N752 coding change in DNA polymerase gene (ORF30). J. Vet. Med. Sci. 2008;70:505–511.
    doi: 10.1292/jvms.70.505pubmed: 18525176google scholar: lookup
  14. Abdelgawad A, Azab W, Damiani A.M., Baumgartner K, Will H, Osterrieder N, Greenwood A.D. Zebra-borne equine herpesvirus type 1 (EHV-1) infection in non-African captive mammals.. Vet. Microbiol. 2014;169:102–106.
    doi: 10.1016/j.vetmic.2013.12.011pubmed: 24440374google scholar: lookup
  15. Greenwood A.D., Tsangaras K, Ho S.Y.W., Szentiks C.A., Nikolin V.M., Ma G, Damiani A, East M.L., Lawrenz A, Hofer H. A potentially fatal mix of herpes in zoos.. Curr. Biol. 2012;22:1727–1731.
    doi: 10.1016/j.cub.2012.07.035pubmed: 22902751google scholar: lookup
  16. Kennedy M.A., Ramsay E., Diderrich V., Richman L., Allen G.P., Potgieter L.N.D.. Encephalitis associated with a variant of equine herpesvirus 1 in a Thomson’s Gazelle (Gazella thomsoni). J. Zoo Wildl. Med. 1996;27:533–538.
  17. Montali R.J., Allen G.P., Bryans J.T., Phillips L.G., Bush M.. Equine herpesvirus type 1 abortion in an onager and suspected herpesvirus myelitis in a zebra. J. Am. Vet. Med. Assoc. 1985;187:1248–1249.
    pubmed: 3001004
  18. Wolff P.L., Meehan T.P., Basgall E.J., Allen G.P., Sundberg J.P.. Abortion and perinatal foal mortality associated with equine herpesvirus type 1 in a herd of Grevy’s zebra. J. Am. Vet. Med. Assoc. 1986;189:1185–1186.
    pubmed: 2851577
  19. Gibson J., Slater J., Field H.. The pathogenicity of Ab4p, the sequenced strain of equine herpesvirus-1, in specific pathogen-free foals. Virology 1992;189:317–319.
    doi: 10.1016/0042-6822(92)90707-Vpubmed: 1318607google scholar: lookup
  20. Telford E.A., Watson M.S., McBride K., Davison A.J.. The DNA sequence of equine herpesvirus-1. Virology 1992;189:304–316.
    doi: 10.1016/0042-6822(92)90706-Upubmed: 1318606google scholar: lookup
  21. Awan A.R., Chong Y.-C., Field H.J.. The pathogenesis of equine herpesvirus type 1 in the mouse: A new model for studying host responses to the infection. J. Gen. Virol. 1990;71:1131–1140.
    doi: 10.1099/0022-1317-71-5-1131pubmed: 2161048google scholar: lookup
  22. Ibrahim E.S.M., Pagmajav O., Yamaguchi T., Matsumura T., Fukushi H.. Growth and virulence alterations of equine herpesvirus 1 by insertion of a green fluorescent protein gene in the intergenic region between ORFs 62 and 63. Microbiol. Immunol. 2004;48:831–842.
  23. Kasem S., Yu M.H.H., Yamada S., Kodaira A., Matsumura T., Tsujimura K., Madbouly H., Yamaguchi T., Ohya K., Fukushi H.. The ORF37 (UL24) is a neuropathogenicity determinant of equine herpesvirus 1 (EHV-1) in the mouse encephalitis model. Virology 2010;400:259–270.
    doi: 10.1016/j.virol.2010.02.012pubmed: 20199788google scholar: lookup
  24. Okada A., Izume S., Ohya K., Fukushi H.. Equine herpesvirus type 1 tegument protein VP22 is not essential for pathogenicity in a hamster model, but is required for efficient viral growth in cultured cells. J. Vet. Med. Sci. 2015;77:1293–1297.
    doi: 10.1292/jvms.14-0648pmc: PMC4638299pubmed: 25948053google scholar: lookup
  25. Gosztonyi G., Borchers K., Ludwig H.. Pathogenesis of equine herpesvirus-1 infection in the mouse model. APMIS 2009;117:10–21.
  26. Frame M.C., McGeoch D.J., Rixon F.J., Orr A.C., Marsden H.S.. The 10K virion phosphoprotein encoded by gene US9 from herpes simplex virus type 1. Virology 1986;150:321–332.
    doi: 10.1016/0042-6822(86)90297-7pubmed: 3008413google scholar: lookup
  27. McGeoch D.J., Dolan A., Donald S., Rixon F.J.. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J. Mol. Biol. 1985;181:1–13.
    doi: 10.1016/0022-2836(85)90320-1pubmed: 2984429google scholar: lookup
  28. McGraw H.M., Awasthi S., Wojcechowskyj J.A., Friedman H.M.. Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9. J. Virol. 2009;83:8315–8326.
    doi: 10.1128/JVI.00633-09pmc: PMC2738194pubmed: 19570876google scholar: lookup
  29. Davison A.J., Scott J.E.. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 1986;67:1759–1816.
    doi: 10.1099/0022-1317-67-9-1759pubmed: 3018124google scholar: lookup
  30. Van Zijl M., van der Gulden H., de Wind N., Gielkens A., Berns A.. Identification of two genes in the unique short region of pseudorabies virus; comparison with herpes simplex virus and varicella-zoster virus. J. Gen. Virol. 2001;71:1747–1755.
    doi: 10.1099/0022-1317-71-8-1747pubmed: 2167928google scholar: lookup
  31. Killeen AM, Harrington L, Wall LV, Kelly DC. Nucleotide sequence analysis of a homologue of herpes simplex virus type 1 gene US9 found in the genome of simian herpes B virus.. J. Gen. Virol. 1992;73:195–199.
    doi: 10.1099/0022-1317-73-1-195pubmed: 1309859google scholar: lookup
  32. Leung-Tack P, Audonnet JC, Riviere M. The complete DNA sequence and the genetic organization of the short unique region (US) of the bovine herpesvirus type 1 (ST strain). Virology 1994;199:409–421.
    doi: 10.1006/viro.1994.1139pubmed: 8122370google scholar: lookup
  33. Willemse MJ, Strijdveen IG, van Schooneveld SH, van den Berg MC, Sondermeijer PJ. Transcriptional analysis of the short segment of the feline herpesvirus type 1 genome and insertional mutagenesis of a unique reading frame.. Virology 1995;208:704–711.
    doi: 10.1006/viro.1995.1202pubmed: 7747442google scholar: lookup
  34. Haanes EJ, Tomlinson CC. Genomic organization of the canine herpesvirus US region.. Virus Res. 1998;53:151–162.
    doi: 10.1016/S0168-1702(97)00152-4pubmed: 9620207google scholar: lookup
  35. Dolan A, Jamieson FE, Cunningham C, Barnett BC, McGeoch DJ. The genome sequence of herpes simplex virus type 2.. J. Virol. 1998;72:2010–2021.
  36. Lyman MG, Kemp CD, Taylor MP, Enquist LW. Comparison of the pseudorabies virus Us9 protein with homologs from other veterinary and human alphaherpesviruses.. J. Virol. 2009;83:6978–6986.
    doi: 10.1128/JVI.00598-09pmc: PMC2704756pubmed: 19420087google scholar: lookup
  37. Chowdhury S, Mahmood S, Simon J, Al-Mubarak A, Zhou Y. The Us9 gene of bovine herpesvirus 1 (BHV-1) effectively complements a Us9-null strain of BHV-5 for anterograde transport, neurovirulence, and neuroinvasiveness in a rabbit model.. J. Virol. 2006;80:4396–4405.
  38. Chowdhury S, Onderci M, Bhattacharjee P, Al-Mubarak A, Weiss M, Zhou Y. Bovine herpesvirus 5 (BHV-5) Us9 is essential for BHV-5 neuropathogenesis.. J. Virol. 2002;76:3839–3851.
  39. Ata EB, Zaghawa A, Ghazy AA, Elsify A, Abdelrahman K, Kasem S, Nayel M. Development and characterization of ORF68 negative equine herpes virus type–1, Ab4p strain.. J. Virol. Methods 2018;261:121–131.
  40. Badr Y, Okada A, Abo-Sakaya R, Beshir E, Ohya K, Fukushi H. Equine herpesvirus type 1 ORF51 encoding UL11 as an essential gene for replication in cultured cells.. Arch. Virol. 2018;163:599–607.
    doi: 10.1007/s00705-017-3650-4pubmed: 29149435google scholar: lookup
  41. Matsumura T, Kondo T, Sugita S, Damiani AM, O’Callaghan DJ, Imagawa H. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.. Virology 1998;242:68–79.
    doi: 10.1006/viro.1997.8984pubmed: 9501037google scholar: lookup
  42. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−∆∆CT Method.. Methods 2001;25:402–408.
    doi: 10.1006/meth.2001.1262pubmed: 11846609google scholar: lookup
  43. Yu MH, Kasem SG, Tsujimura K, Matsumura T, Yanai T, Yamaguchi T, Ohya K, Fukushi H. Diverse pathogenicity of equine herpesvirus 1 (EHV-1) isolates in CBA mouse model.. J. Vet. Med. Sci. 2010;72:301–306.
    doi: 10.1292/jvms.09-0337pubmed: 19959887google scholar: lookup
  44. Robertson D, Savage K, Reis-Filho JS, Isacke CM. Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue.. BMC Cell Biol. 2008;9:13.
    doi: 10.1186/1471-2121-9-13pmc: PMC2288605pubmed: 18366689google scholar: lookup
  45. Howard PW, Howard TL, Johnson DC. Herpes simplex virus membrane proteins gE/gI and US9 act cooperatively to promote transport of capsids and glycoproteins from neuron cell bodies into proximal axons.. J. Virol. 2013;87:403–414.
    doi: 10.1128/JVI.02465-12pmc: PMC3536398pubmed: 23077321google scholar: lookup
  46. Brideau A, Card J, Enquist L. Role of pseudorabies virus Us9, a type II membrane protein, in infection of tissue culture cells and the rat nervous system.. J. Virol. 2000;74:834–845.
  47. Brandimarti R, Roizman B. Us9, a stable lysine-less herpes simplex virus 1 protein, is ubiquitinated before packaging into virions and associates with proteasomes.. Proc. Natl. Acad. Sci. USA 1997;94:13973–13978.
    doi: 10.1073/pnas.94.25.13973pmc: PMC28417pubmed: 9391137google scholar: lookup
  48. Brideau A, Banfield BW, Enquist L. The Us9 gene product of pseudorabies virus, an alphaherpesvirus, is a phosphorylated, tail-anchored type II membrane protein.. J. Virol. 1998;72:4560–4570.
  49. Peck SC. Analysis of protein phosphorylation: Methods and strategies for studying kinases and substrates.. Plant Journal 2006;45:512–522.
  50. Lee BJ, Weiss ML, Mosier D, Chowdhury SI. Spread of bovine herpesvirus type 5 (BHV-5) in the rabbit brain after intranasal inoculation.. J. Neurovirol. 1999;5:474–484.
    doi: 10.3109/13550289909045376pubmed: 10568884google scholar: lookup
  51. Fukushi H, Taniguchi A, Yasuda K, Yanai T, Masegi T, Yamaguchi T, Hirai K. A hamster model of equine herpesvirus 9 induced encephalitis.. J. Neurovirol. 2000;6:314–319.
    doi: 10.3109/13550280009030757pubmed: 10951555google scholar: lookup
  52. Narita M, Uchimura A, Kawanabe M, Fukushi H, Hirai K. Invasion and spread of equine herpesvirus 9 in the olfactory pathway of pigs after intranasal inoculation.. J. Comp. Pathol. 2001;124:265–272.
    doi: 10.1053/jcpa.2000.0461pubmed: 11437502google scholar: lookup
  53. Enquist L, Tomishima M, Gross S, Smith G. Directional spread of an α-herpesvirus in the nervous system.. Vet. Microbiol. 2002;86:5–16.
    doi: 10.1016/S0378-1135(01)00486-2pubmed: 11888685google scholar: lookup
  54. Tomishima M, Enquist L. A conserved α-herpesvirus protein necessary for axonal localization of viral membrane proteins.. J. Cell Biol. 2001;154:741–752.
    doi: 10.1083/jcb.200011146pmc: PMC2196449pubmed: 11502759google scholar: lookup
  55. Tomishima M, Smith G, Enquist L. Sorting and transport of alpha herpesviruses in axons.. Traffic 2001;2:429–436.

Citations

This article has been cited 1 times.
  1. Kasem S, Abdel-Moneim AS, Fukushi H. Effect of thymidine kinase-deficiency (∆ORF38) on neuropathogenicity of equine herpesvirus-1 in the mouse model and expression of neighboring genes.. Virus Genes 2025 Apr;61(2):179-192.
    doi: 10.1007/s11262-024-02128-wpubmed: 39681760google scholar: lookup